Lannett Company, Inc. (NYSE AMEX: LCI) has received approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE